Core Viewpoint - The increasing attention on index-enhanced funds, which combine characteristics of both indexation and active management, reflects a growing trend in the investment landscape, particularly in the context of a structural bull market this year [1][9]. Group 1: Index-Enhanced Funds Overview - Traditional index funds aim to replicate indices, focusing on market beta, while enhanced ETFs add active research strategies to uncover alpha returns while managing tracking errors [1][2]. - Jiashi Fund has launched a range of index-enhanced products that have delivered excess returns, outperforming their benchmarks [1][9]. Group 2: Performance of Jiashi Enhanced Funds - Jiashi Zhongzheng Semiconductor Index Enhanced A (014854) achieved a year-to-date return of 51.21%, surpassing its benchmark of 49.07% [2][10]. - Jiashi's ChiNext Enhanced ETF (159675) recorded a return of 49.09%, exceeding its benchmark return of 44.40% by nearly 5 percentage points [2][10]. - Jiashi Zhongzheng 500 Index Enhanced A (008778) returned 29.25%, outperforming its benchmark of 22.84% by over 6 percentage points [2][10]. - Jiashi Zhongzheng 1000 Index Enhanced A (016776) achieved a return of 33.75%, exceeding its benchmark of 22.82% by over 10 percentage points [2][10]. Group 3: Product Development and Strategy - Jiashi Fund has expanded its index-enhanced product offerings, including the first Shanghai Composite Index Enhanced ETF and the first batch of STAR Market Index Enhanced ETFs [3][11]. - The firm emphasizes a combination of active and passive strategies to explore smarter beta opportunities, leveraging over 20 years of investment research experience [3][11]. - Jiashi's Chief Investment Officer for Smart-Beta and Index Investment, Liu Bin, highlighted the focus on investment success rates while optimizing for quality sectors, companies, and pricing to generate alpha [3][11].

Group 1 - The core viewpoint of the news is that Jianfan Bio (300529.SZ) reported a decrease in institutional investor holdings in its A-shares, with a total of 51.87 million shares held by six institutions, representing 6.49% of the total share capital, down by 2.00 percentage points from the previous quarter [1] Group 2 - In the public fund sector, two public funds increased their holdings, including Huabao Zhongzheng Medical ETF and Southern Zhongzheng 500 ETF, with an increase ratio of 0.25% [2] - Two public funds decreased their holdings, namely, Zhaoshang Guozhen Biomedical Index A and Yifangda Growth Enterprise ETF, with a decrease ratio of 0.11% [2] - Six public funds did not disclose their holdings in the current period, including Guangda Baodexin Credit Enhancement Bond A and others [2] Group 3 - Regarding foreign investment, the Hong Kong Central Clearing Limited is noted as an institution that did not disclose its holdings in the current period [3]

Group 1 - StarNet RuiJie (002396.SZ) released its 2024 annual report on April 3, 2025, indicating that 197 institutional investors disclosed holdings of 244 million A-shares, accounting for 41.47% of the total share capital [1] - The top ten institutional investors include Fujian Electronic Information Group, Hong Kong Central Clearing Limited, Central Huijin Asset Management, and several others, with a combined holding ratio of 38.29%, which decreased by 0.71 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, five public funds reported a decrease in holdings compared to the previous quarter, with a reduction ratio of 0.46% [2] - A total of 188 new public funds were disclosed this period, including several notable funds such as the招商量化精选股票发起式A and 华夏中证5G通信主题ETF [2] - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 2.00% compared to the previous period [2]